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Background: In randomized stent trials, MI occurring after PCI is a measure of stent safety. MI is often defined by cardiac enzyme elevation or 
diagnostic EKG changes regardless of the angiographic location of the culprit lesion. Hence, the relation of post-PCI MI to the stented vessel cannot 
be ascertained.
Methods: In 1228 patients presenting with STEMI (n=554) or NSTEMI (n=674) who underwent successful stenting, we prospectively assessed the 
incidence of re-MI (defined per NCDR 4.4) and the location of the culprit lesion.
Results: At a mean follow-up duration of 1285 ± 706 days, 102 patients suffered re-MI, including 72 who underwent follow-up angiography. The 
culprit lesion causing re-MI was noted to be in the stented vessel in 48 (47%), and in a different vessel in 24 (24%) patients (see figure).
Conclusion: A significant number of MI occurring after PCI are unrelated to the stented vessel. Hence, the use of MI - without angiographic 
confirmation of the culprit lesion - as a safety end point in stent trials should be abandoned. Future randomized stent studies should uniformly 
report target vessel failure, which includes only those MI events that occur in the stented vessel.
 
